Register


Create a profile to access all of our events, including options to sign up for our in person meetings and to view the online content from our past conferences!


Video Platform

View all the content from the last 12 months

MD Newsletter

Stay up to date with everything MD Education

Tickets & Events

Save your space and register for our future events

Select what applies to you




Login

Gaining access to MD Education’s premium offerings is only a button away! Enter your email and password to get educated.

MD-Education logo
Register / Login
We're evolving!

The website is currently being upgraded to include our new suite of offerings. Check back at the end of the month for a breakdown of our new services!


Questions? Contact us at:


office@md-education.com

Want Cookies?


Currently, we're using cookies for tracking purposes. By tracking, we mean what pages of MD Education you visit, what forms you submit and how you interact with our site. We do not sell this data to anybody. Currently, the Cookies we use are needed to collect form data through HubSpot.


If you'd like to see what we do with your data, head over to our Privacy Policy


7th Annual

Thank you for registering to our ASH Satillite Symposium!

Please check your emails for registration confirmation.


MPN-MDS

EU Focus Meeting

Updating Knowledge & Clinical Practice in 2025


Location TBD

Friday 12 September 2025

Presentations will be available online for 12 months

Meeting content distributed to 12,000+ HCPs

For more information get in touch!

=

Co-chair

Alessandro M. Vannucchi, MD

University of Florence, Italy

=

Co-chair

Rami Komrokji, MD

Moffitt Cancer Center, Florida

Dear Colleagues and Friends,


We are delighted to extend our warmest invitation to the multinational congress MPN-MDS EU Focus 2025, to be held at Location TBD on the 12th of September, 2025.


This congress provides pivotal collaboration aimed at advancing MPN-MDS research and patient treatment.


This congress presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts from around the world.


Engage in riveting presentations, participate in thought-provoking debates, round-table discussions, and connect with peers at informal social gatherings.


All congress content will be accessible online for a full year, reaching an extensive audience of healthcare professionals worldwide.


People stood in a circle, smiling, with a cup of water

Agenda & Faculty

MPN-MDS EU Focus Meeting, Friday 12 September 2025

8:00 AM

Registration Opens

8:45 AM

Opening Remarks – Ryan Fitzpatrick, CEO, MD Education

9:00 AM

TP53 Abnormalities in Myeloid Neoplasms

=

Naval Daver, MD

MD Anderson Cancer Center, Houston, Texas

Special Interest Lecture

Session 1: Pathophysiology of MPN and MDS

9:20 AM

The Inflammatory Status of MPN

=

Steffen Koschmieder, MD

University Hospital RWTH Aachen, Aachen, Germany

9:35 AM

The Molecular Landscape of MPN

=

Jyoti Nangalia, MD

Cambridge University Hospitals NHS Foundation Trust, UK

9:50 AM

The Inflammatory Status of MDS

=

Astrid Marta Olsnes, MD

University of Bergen, Norway

10:05 AM

The Immune System Status in MDS

=

Shahram Kordasti, MD

King’s College London, UK

10:20 AM

Panel Discussion

10:35 AM

Coffee Break & Networking

10:50 AM

Symptom Assessment and Value in MPN: From Clinical Trials to Real World

=

Ruben Mesa, MD

Atrium Health Levine Cancer, Charlotte, North Carolina

Special Interest Lecture

Session 2: Polycythemia Vera (PV)

11:10 AM

Debate: Is Molecular Response Clinically Meaningful in PV

=

Yes

Paola Guglielmelli, MD

University of Florence, Italy

=

No

Rajko Kušec, MD

Dubrava University Hospital, Croatia

11:30 AM

Debate Discussion

11:40 AM

Debate: Current Management of Low-risk PV

=

Interferon

Jean-Jacques Kiladjian, MD

Université Paris Cité, France

=

Phlebotomy

Speaker TBD

TBD

12:00 PM

Debate Discussion

12:10 PM

Lunch Break, Networking, and Faculty Photo

1:00 PM

Independent Expert Discussion

Session 3: Essential Thrombocytopenia (ET) and Special Situations